SignatureFD’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $140K | Sell |
1,685
-100
| -6% | -$8.29K | ﹤0.01% | 1073 |
|
|
2025
Q1 | $145K | Sell |
1,785
-549
| -24% | -$44.5K | ﹤0.01% | 1030 |
|
|
2024
Q4 | $210K | Buy |
2,334
+598
| +34% | +$53.8K | ﹤0.01% | 853 |
|
|
2024
Q3 | $171K | Buy |
1,736
+12
| +0.7% | +$1.19K | ﹤0.01% | 947 |
|
|
2024
Q2 | $160K | Buy |
1,724
+1
| +0.1% | +$93 | ﹤0.01% | 921 |
|
|
2024
Q1 | $164K | Hold |
1,723
| – | – | ﹤0.01% | 923 |
|
|
2023
Q4 | $154K | Sell |
1,723
-425
| -20% | -$38K | ﹤0.01% | 909 |
|
|
2023
Q3 | $157K | Buy |
2,148
+1,024
| +91% | +$74.8K | ﹤0.01% | 834 |
|
|
2023
Q2 | $93.5K | Buy |
1,124
+4
| +0.4% | +$333 | ﹤0.01% | 1095 |
|
|
2023
Q1 | $85.4K | Hold |
1,120
| – | – | ﹤0.01% | 1124 |
|
|
2022
Q4 | $93K | Hold |
1,120
| – | – | ﹤0.01% | 1044 |
|
|
2022
Q3 | $89K | Buy |
1,120
+20
| +2% | +$1.59K | ﹤0.01% | 1017 |
|
|
2022
Q2 | $82K | Buy |
1,100
+941
| +592% | +$70.1K | ﹤0.01% | 1068 |
|
|
2022
Q1 | $14K | Sell |
159
-154
| -49% | -$13.6K | ﹤0.01% | 2014 |
|
|
2021
Q4 | $35K | Hold |
313
| – | – | ﹤0.01% | 1514 |
|
|
2021
Q3 | $39K | Sell |
313
-2
| -0.6% | -$249 | ﹤0.01% | 1445 |
|
|
2021
Q2 | $43K | Buy |
315
+215
| +215% | +$29.3K | ﹤0.01% | 1350 |
|
|
2021
Q1 | $14K | Hold |
100
| – | – | ﹤0.01% | 1718 |
|
|
2020
Q4 | $14K | Buy |
+100
| New | +$14K | ﹤0.01% | 1584 |
|